Adjuvant Treatment of Melanoma
We have prepared this document in an effort to provide useful information to physicians caring for patients with melanoma. The suggestions contained herein are intended to be helpful in providing some guidance regarding patient care; the individual situation will be different for each patient and the suggestions should be modified accordingly.
Click for full details.

Therapy of Metastatic Melanoma (Stage IV)
Therapy of disseminated melanoma depends on the specific details of the disease in the individual patient and the patient’s philosophy. This document is intended to provide an overview of therapeutic options which can be considered. The only agents approved by the FDA for therapy of patients with metastatic melanoma are dacarbazine (DTIC) and Interleukin-2 (IL-2).
Click for full details.